Current:Home > ContactSen. Sanders pushes NIH to rein in drug prices -Aspire Money Growth
Sen. Sanders pushes NIH to rein in drug prices
View
Date:2025-04-12 09:34:20
Can the National Institutes of Health bring down drug prices? It doesn't approve new medicines or pay for them, but its role in drug research gives it surprising leverage.
Sen. Bernie Sanders, chairman of the Health, Education, Labor and Pensions committee, voted against confirmation of Dr. Monica Bertagnolli as NIH director. Sanders, a Vermont independent who caucuses with the Democrats in the Senate, said that he didn't think Bertagnolli was prepared to stand up to the pharmaceutical industry.
But Sanders tells NPR he plans to work with Bertagnolli, who was confirmed Nov. 7. He says something has to change at the NIH, which spends billions of dollars each year on biomedical research that lays the foundation for lucrative profits for the drug industry.
"And yet, despite the huge amount of money that taxpayers spend developing these drugs, the drug companies get the product and they end up charging us the highest prices in the world for it," Sanders says.
Government contracts could exert leverage
The Moderna COVID vaccine is an example of the problem, he says. The vaccine was developed with the National Institute of Allergy and Infectious Diseases, part of the NIH. And the government agreed to buy 100 million doses even if it failed clinical trials, wasn't authorized by the Food and Drug Administration and all those doses wound up in the trash.
Ameet Sarpatwari, assistant director of the Program on Regulation, Therapeutics and Law at Harvard Medical School, says the government could have made more use of its leverage as a funder. "That could have been to ensure reasonable pricing for Americans at the very least, ensuring that Americans aren't paying more than people in other countries," he says.
Moderna increased the price of its COVID shot this year from about $26 a dose to $130 a dose. The company has downplayed NIH's role.
Generally, the pharmaceutical industry discounts the importance of NIH-funded research in its work. But Sarpatwari says the NIH is actually the largest single funder of biomedical research in the world.
A lot could be built into NIH contracts to protect Americans. "It's quite possible to at least put in terms that will ensure fair access to the fruits of all of that support," he says, adding the NIH has been hesitant to flex its muscles on pricing.
Sanders asks for scrutiny of licensing deal
Sanders wants that to change and says he hopes that the agency will be less cozy with the pharmaceutical industry under new leadership. He sent a letter last month asking for the administration to investigate NIH moves to grant an exclusive patent license for a cervical cancer drug developed at the agency to a mysterious startup incorporated in Delaware with no website.
The startup, Scarlet TCR, has a relationship with a former NIH employee and the deal could allow the company to someday charge high prices for a government invention.
The agency says no decision has been made regarding Scarlet TCR.
"NIH shares concerns about high drug prices and the burden they place on patients and their families," NIH spokesperson Renate Myles wrote in an email to NPR. "As stated during her Senate confirmation hearing, Dr. Bertagnolli has expressed her commitment to ensuring that the benefits of NIH-funded research are affordable and available to all the Americans."
Bertagnolli will work with Congress, Myles added.
veryGood! (67325)
Related
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- Lionel Messi follows up Luis Suárez's tally with goal of his own for Inter Miami
- C.J. Gardner-Johnson apologizes to Eagles fans for 'obnoxious' comment following reunion
- South Dakota legislator calls for inquiry into Gov. Noem’s Texas dental trip and promo video
- Paris Hilton, Nicole Richie return for an 'Encore,' reminisce about 'The Simple Life'
- Dollar Tree to close nearly 1,000 stores, posts surprise fourth quarter loss
- 1 dead and 1 missing after kayak overturns on Connecticut lake
- Federal judge finds Flint, Michigan, in contempt over lead water pipe crisis
- Grammy nominee Teddy Swims on love, growth and embracing change
- Mega Millions' most drawn numbers may offer clues for March 15, 2024, drawing
Ranking
- IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power
- Dodge drops the Challenger, flexes new 2024 Charger Daytona EV
- Gwyneth Paltrow Reveals How She Felt After Kourtney Kardashian's Poosh Was Compared to Goop
- Lionel Messi follows up Luis Suárez's tally with goal of his own for Inter Miami
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- Michigan jury returning to decide fate of school shooter’s father in deaths of 4 students
- Georgia House speaker aims to persuade resistant Republicans in voucher push
- Biden heads to the Michigan county emerging as the swing state’s top bellwether
Recommendation
Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
Gwyneth Paltrow Reveals How She Felt After Kourtney Kardashian's Poosh Was Compared to Goop
Former NFL coach Jon Gruden lands advisory role with football team in Italy
After 50 years, Tommy John surgery is evolving to increase success and sometimes speed return
Scoot flight from Singapore to Wuhan turns back after 'technical issue' detected
Los Angeles Chargers' Joe Hortiz, Jim Harbaugh pass first difficult test
Royal insider says Princess Kate photo scandal shows wheels are coming off Kensington Palace PR
GOP candidate for Senate in New Jersey faced 2020 charges of DUI, leaving scene of accident